Intensive Lipid Lowering Therapy among patients with Coronary Artery Disease: a Middle Eastern tertiary care center experience

Torkom Garabedian, Alain Rizkallah, George E. Sakr, Samir Alam, Hussain A. Isma'eel

Keywords


Coronary Artery Disease; Lipid Lowering Therapy

Full Text:

PDF HTML

References


European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, et al., ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011.32(14): p. 1769-818. doi: 10.1093/eurheartj/ehr158.

Stone, N.J., et al., 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2014. 129(25 Suppl 2): p. S1-45. doi: 10.1161/01.cir.0000437738.63853.7a.

PL Detail-Document, Statin Dose Comparison (U.S.). Pharmacist’s Letter/Prescriber’s Letter. May 2012.

Robert S. Rosenson.,et al., Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease. J Am Coll Cardiol 2015;65:270–7. doi: 10.1016/j.jacc.2014.09.088.

Armitage J. The safety of statins in clinical practice. Lancet 2007;Nov 24;370(9601):1781-90. DOI: http://dx.doi.org/10.1016/S0140-

(07)60716-8

Bottorff MB. Statin Safety and Drug Interactions: Clinical Implications. Am J Cardiol. 2006 Apr 17;97(8A):27C-31C. DOI: http://dx.doi.org/10.1016/j.amjcard.2005.12.007

Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment–risk paradox. JAMA. 2004; 291: 1864–1870. doi:10.1001/jama.291.15.1864.

Vancheri, F. Trends in coronary heart disease mortality and statin utilization in two European areas with different population risk levels: Stockholm and Sicily. International Cardiovascular Forum Journal. 2014;1:140-146. http://dx.doi.org/10.17987/icfj.v1i3.39

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v6i0.160

Copyright (c) 2016 Torkom Garabedian, Alain Rizkallah, George E. Sakr, Samir Alam, Hussain A. Isma'eel

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.